What are the major opportunities in the Acute Respiratory Distress Syndrome (ARDS) market? What are the strategies for the Acute Respiratory Distress Syndrome (ARDS) market?

For detailed insights on the major opportunities and strategies in the Acute Respiratory Distress Syndrome (ARDS) market, Read More

How does the Acute Respiratory Distress Syndrome (ARDS) market relate to the overall economy and other similar markets?

For detailed insights on Acute Respiratory Distress Syndrome (ARDS)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Acute Respiratory Distress Syndrome (ARDS) market growth? SWOT analysis of the Acute Respiratory Distress Syndrome (ARDS) market.

For detailed insights on the key dynamics influencing the Acute Respiratory Distress Syndrome (ARDS) market growth and SWOT analysis of the Acute Respiratory Distress Syndrome (ARDS) industry, Read More

Acute Respiratory Distress Syndrome (ARDS) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Acute Respiratory Distress Syndrome (ARDS) Market Report 2026

Name: Acute Respiratory Distress Syndrome (ARDS) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes), By Severity (Mild, Moderate, Severe), By End User (Hospitals, Clinics, Ambulatory Service Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Acute Respiratory Distress Syndrome (ARDS) Market Overview

• Acute Respiratory Distress Syndrome (ARDS) market size has reached to $1.41 billion in 2025

• Expected to grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%

• Growth Driver: Increasing Number Of Respiratory Illness Are Anticipated To Positively Impact The Acute Respiratory Distress Syndrome (ARDS) Market

• Market Trend: Innovations In Immune Modulators Offer New Therapeutic Options In Acute Respiratory Distress Syndrome (ARDS)

• North America was the largest region in 2025.

What Is Covered Under Acute Respiratory Distress Syndrome (ARDS) Market?

Acute respiratory distress syndrome (ARDS) is a potentially fatal illness characterized by non-compliant, or stiff lungs and low oxygenation. It is an acute, diffuse and inflammatory form of lung injury that can occur in seriously ill patients. Acute respiratory distress syndrome (ARDS) treatment involves mechanical ventilation with low tidal volumes and positive end-expiratory pressure (PEEP) to support oxygenation and prevent lung injury.

The main types of services involved in acute respiratory distress syndrome (ARDS) are diagnosis and treatment. Diagnosis is the process of separating a disease or disorder from other potential disorders and defining its nature. The diagnosis of acute respiratory distress syndrome (ARDS) is based on the physical exam, chest X-ray and oxygen levels. It can be caused by COVID-19 disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia and others with severity ranging from mild, moderate and severe. The major end users are hospitals, clinics, ambulatory service centers and others.

Acute Respiratory Distress Syndrome (ARDS) Market Global Report 2026 Market Report bar graph

What Is The Acute Respiratory Distress Syndrome (ARDS) Market Size and Share 2026?

The acute respiratory distress syndrome (ards) market size has grown rapidly in recent years. It will grow from $1.41 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising incidence of respiratory infections, growing hospital icu infrastructure, increasing awareness of ards management protocols, limited availability of advanced ventilation devices, adoption of supportive care practices.

What Is The Acute Respiratory Distress Syndrome (ARDS) Market Growth Forecast?

The acute respiratory distress syndrome (ards) market size is expected to see rapid growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to technological advancements in mechanical ventilation and ecmo systems, increasing r&d in ards therapeutics, expansion of critical care units globally, rising investment in personalized patient management solutions, growing prevalence of severe pneumonia and sepsis. Major trends in the forecast period include rising adoption of mechanical ventilation and ecmo devices, increasing prevalence of ards due to covid-19 and other respiratory diseases, growing use of advanced diagnostic tests for early detection, expansion of critical care and icu facilities, focus on personalized and supportive care management.

Book your 30 minutes free consultation with our research experts

Global Acute Respiratory Distress Syndrome (ARDS) Market Segmentation

1) By Type: Diagnosis, Treatment

2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes

3) By Severity: Mild, Moderate, Severe

4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users

Subsegments:

1) By Diagnosis: Imaging Tests, Blood Tests

2) By Treatment: Mechanical Ventilation, Medications, Extracorporeal Membrane Oxygenation (ECMO), Supportive Care

What Is The Driver Of The Acute Respiratory Distress Syndrome (ARDS) Market?

The increasing number of respiratory illnesses is expected to propel the growth of the acute respiratory distress syndrome (ARDS) market going forward. Respiratory illness refers to a group of medical conditions that affect the respiratory system, including the airways and lungs, and can cause difficulty breathing. The increasing number of respiratory illnesses, like COVID-19, is one of the major factors driving the growth of the acute respiratory distress syndrome (ARDS) market. As more people develop respiratory illnesses, the demand for ARDS treatments and therapies is likely to increase, leading to market growth. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, the increasing number of respiratory illnesses is driving the growth of the acute respiratory distress syndrome (ARDS) industry.

Key Players In The Global Acute Respiratory Distress Syndrome (ARDS) Market

Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Medtronic plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, Smiths Medical Inc., Dräger Safety AG & Co. KGaA, Getinge AB, Mallinckrodt plc, Masimo Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Windtree Therapeutics Inc., Faron Pharmaceuticals Oy

Global Acute Respiratory Distress Syndrome (ARDS) Market Trends and Insights

Major companies operating in the acute respiratory distress syndrome market are focusing on developing advanced immune modulators to enhance patient survival and reduce inflammation. Immune modulators are therapies that restore immune balance by targeting dysfunctional inflammatory pathways without suppressing overall immune function. For instance, in June 2025, BioAegis Therapeutics, a US-based clinical-stage company, received FDA Fast Track designation for its lead product, recombinant human plasma gelsolin (rhu-pGSN), for the treatment of ARDS. The therapy works by replenishing gelsolin, a critical immune regulatory protein, to modulate NLRP3 inflammasome activation, enhance microbial clearance, remove toxic actin and inflammatory mediators, and regulate macrophage activity. rhu-pGSN is being evaluated in a 600-patient global Phase 2b trial for moderate to severe ARDS and may also be made available through the FDA Expanded Access or Compassionate Use program. The Fast Track designation allows for expedited regulatory interactions, rolling review of marketing applications, and eligibility for priority review, potentially accelerating its time to market and offering a novel therapeutic option for patients with limited alternatives.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Acute Respiratory Distress Syndrome (ARDS) Market?

In April 2024, Healios K.K., a Japan-based regenerative medicine-focused biotech company, acquired all of the assets of Athersys, Inc., including its off-the-shelf stem cell therapy MultiStem (invimestrocel), via a credit bid of approximately $2.25 million. Through this acquisition, Healios gains full control of the MultiStem intellectual property and R&D capabilities, enabling it to further develop the therapy globally, especially for acute respiratory distress syndrome (ARDS). Athersys, Inc. is a US-based provider of acute respiratory distress syndrome.

Regional Outlook

North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Respiratory Distress Syndrome (ARDS) Market?

The acute respiratory distress syndrome (ARDS) market includes revenues earned by entities by providing resolution and recovery services, medication, supplemental oxygen and mechanical ventilation. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute respiratory distress syndrome (ARDS) market consists of sales of neuromuscular blockers, corticosteroids, monitoring devices, diagnostic devices and therapeutic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acute Respiratory Distress Syndrome (ARDS) Market Report 2026?

The acute respiratory distress syndrome (ards) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acute respiratory distress syndrome (ards) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Acute Respiratory Distress Syndrome (ARDS) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.56 billion
Revenue Forecast In 2035	$2.42 billion
Growth Rate	CAGR of 10.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Cause, Severity, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Medtronic plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, Smiths Medical Inc., Dräger Safety AG & Co. KGaA, Getinge AB, Mallinckrodt plc, Masimo Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Windtree Therapeutics Inc., Faron Pharmaceuticals Oy
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Acute Respiratory Distress Syndrome (ARDS) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Acute Respiratory Distress Syndrome (ARDS) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Acute Respiratory Distress Syndrome (ARDS) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Acute Respiratory Distress Syndrome (ARDS) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Mechanical Ventilation And Ecmo Devices

4.2.2 Increasing Prevalence Of Ards Due To Covid-19 And Other Respiratory Diseases

4.2.3 Growing Use Of Advanced Diagnostic Tests For Early Detection

4.2.4 Expansion Of Critical Care And Icu Facilities

4.2.5 Focus On Personalized And Supportive Care Management

5. Acute Respiratory Distress Syndrome (ARDS) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Ambulatory Service Centers

5.4 Critical Care And Icu Units

5.5 Other Healthcare Facilities

6. Acute Respiratory Distress Syndrome (ARDS) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Acute Respiratory Distress Syndrome (ARDS) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Acute Respiratory Distress Syndrome (ARDS) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Acute Respiratory Distress Syndrome (ARDS) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Acute Respiratory Distress Syndrome (ARDS) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Acute Respiratory Distress Syndrome (ARDS) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Acute Respiratory Distress Syndrome (ARDS) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Acute Respiratory Distress Syndrome (ARDS) Market Segmentation

9.1. Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnosis, Treatment

9.2. Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes

9.3. Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mild, Moderate, Severe

9.4. Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Ambulatory Service Centers, Other End Users

9.5. Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging Tests, Blood Tests

9.6. Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mechanical Ventilation, Medications, Extracorporeal Membrane Oxygenation (ECMO), Supportive Care

10. Acute Respiratory Distress Syndrome (ARDS) Market Regional And Country Analysis

10.1. Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market

11.1. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Acute Respiratory Distress Syndrome (ARDS) Market

12.1. China Acute Respiratory Distress Syndrome (ARDS) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Acute Respiratory Distress Syndrome (ARDS) Market

13.1. India Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Acute Respiratory Distress Syndrome (ARDS) Market

14.1. Japan Acute Respiratory Distress Syndrome (ARDS) Market Overview

14.2. Japan Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Acute Respiratory Distress Syndrome (ARDS) Market

15.1. Australia Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Acute Respiratory Distress Syndrome (ARDS) Market

16.1. Indonesia Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Acute Respiratory Distress Syndrome (ARDS) Market

17.1. South Korea Acute Respiratory Distress Syndrome (ARDS) Market Overview

17.2. South Korea Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Acute Respiratory Distress Syndrome (ARDS) Market

18.1. Taiwan Acute Respiratory Distress Syndrome (ARDS) Market Overview

18.2. Taiwan Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Acute Respiratory Distress Syndrome (ARDS) Market

19.1. South East Asia Acute Respiratory Distress Syndrome (ARDS) Market Overview

19.2. South East Asia Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Acute Respiratory Distress Syndrome (ARDS) Market

20.1. Western Europe Acute Respiratory Distress Syndrome (ARDS) Market Overview

20.2. Western Europe Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Acute Respiratory Distress Syndrome (ARDS) Market

21.1. UK Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Acute Respiratory Distress Syndrome (ARDS) Market

22.1. Germany Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Acute Respiratory Distress Syndrome (ARDS) Market

23.1. France Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Acute Respiratory Distress Syndrome (ARDS) Market

24.1. Italy Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Acute Respiratory Distress Syndrome (ARDS) Market

25.1. Spain Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Acute Respiratory Distress Syndrome (ARDS) Market

26.1. Eastern Europe Acute Respiratory Distress Syndrome (ARDS) Market Overview

26.2. Eastern Europe Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Acute Respiratory Distress Syndrome (ARDS) Market

27.1. Russia Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Acute Respiratory Distress Syndrome (ARDS) Market

28.1. North America Acute Respiratory Distress Syndrome (ARDS) Market Overview

28.2. North America Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Acute Respiratory Distress Syndrome (ARDS) Market

29.1. USA Acute Respiratory Distress Syndrome (ARDS) Market Overview

29.2. USA Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Acute Respiratory Distress Syndrome (ARDS) Market

30.1. Canada Acute Respiratory Distress Syndrome (ARDS) Market Overview

30.2. Canada Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Acute Respiratory Distress Syndrome (ARDS) Market

31.1. South America Acute Respiratory Distress Syndrome (ARDS) Market Overview

31.2. South America Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Acute Respiratory Distress Syndrome (ARDS) Market

32.1. Brazil Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Acute Respiratory Distress Syndrome (ARDS) Market

33.1. Middle East Acute Respiratory Distress Syndrome (ARDS) Market Overview

33.2. Middle East Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Acute Respiratory Distress Syndrome (ARDS) Market

34.1. Africa Acute Respiratory Distress Syndrome (ARDS) Market Overview

34.2. Africa Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Segmentation By Cause, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Acute Respiratory Distress Syndrome (ARDS) Market Regulatory and Investment Landscape

36. Acute Respiratory Distress Syndrome (ARDS) Market Competitive Landscape And Company Profiles

36.1. Acute Respiratory Distress Syndrome (ARDS) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Acute Respiratory Distress Syndrome (ARDS) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Acute Respiratory Distress Syndrome (ARDS) Market Company Profiles

36.3.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Acute Respiratory Distress Syndrome (ARDS) Market Other Major And Innovative Companies

Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, Smiths Medical Inc., Dräger Safety AG & Co. KGaA, Getinge AB, Mallinckrodt plc, Masimo Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG

38. Global Acute Respiratory Distress Syndrome (ARDS) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Acute Respiratory Distress Syndrome (ARDS) Market

40. Acute Respiratory Distress Syndrome (ARDS) Market High Potential Countries, Segments and Strategies

40.1 Acute Respiratory Distress Syndrome (ARDS) Market In 2030 - Countries Offering Most New Opportunities

40.2 Acute Respiratory Distress Syndrome (ARDS) Market In 2030 - Segments Offering Most New Opportunities

40.3 Acute Respiratory Distress Syndrome (ARDS) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Acute Respiratory Distress Syndrome (ARDS) Market, Overview Of Key Products - Product Examples

Table 2: Global Acute Respiratory Distress Syndrome (ARDS) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Acute Respiratory Distress Syndrome (ARDS) Market, Supply Chain Analysis

Table 4: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Raw Material Providers

Table 5: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Resource Providers

Table 6: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Manufacturers (Suppliers)

Table 7: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Distributors And Channel Partners

Table 8: Global Acute Respiratory Distress Syndrome (ARDS) Market, Key Technologies & Future Trends

Table 9: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Trends

Table 10: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major End Users

Table 11: Global Acute Respiratory Distress Syndrome (ARDS) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Acute Respiratory Distress Syndrome (ARDS) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Acute Respiratory Distress Syndrome (ARDS) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Acute Respiratory Distress Syndrome (ARDS) Market - TAM, US$ Billion, 2025

Table 15: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Acute Respiratory Distress Syndrome (ARDS) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Acute Respiratory Distress Syndrome (ARDS) Market - Company Scoring Matrix

Table 97: Johnson & Johnson Services Inc. Financial Performance

Table 98: Novartis AG Financial Performance

Table 99: GlaxoSmithKline plc Financial Performance

Table 100: Medtronic plc Financial Performance

Table 101: Boehringer Ingelheim International GmbH Financial Performance

Table 102: Global Acute Respiratory Distress Syndrome (ARDS) Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Acute Respiratory Distress Syndrome (ARDS) Market, Competitive Dashboard

Table 104: Global Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Cause, 2025 – 2030

Table 107: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Severity, 2025 – 2030

List Of Figures

Figure 1: Global Acute Respiratory Distress Syndrome (ARDS) Market, Overview Of Key Products - Product Examples

Figure 2: Global Acute Respiratory Distress Syndrome (ARDS) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Acute Respiratory Distress Syndrome (ARDS) Market, Supply Chain Analysis

Figure 4: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Raw Material Providers

Figure 5: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Resource Providers

Figure 6: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Manufacturers (Suppliers)

Figure 7: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Distributors And Channel Partners

Figure 8: Global Acute Respiratory Distress Syndrome (ARDS) Market, Key Technologies & Future Trends

Figure 9: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major Trends

Figure 10: Global Acute Respiratory Distress Syndrome (ARDS) Market, Major End Users

Figure 11: Global Acute Respiratory Distress Syndrome (ARDS) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Acute Respiratory Distress Syndrome (ARDS) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Acute Respiratory Distress Syndrome (ARDS) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Acute Respiratory Distress Syndrome (ARDS) Market - TAM, US$ Billion, 2025

Figure 15: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Acute Respiratory Distress Syndrome (ARDS) Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Acute Respiratory Distress Syndrome (ARDS) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Cause, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Acute Respiratory Distress Syndrome (ARDS) Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Acute Respiratory Distress Syndrome (ARDS) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Acute Respiratory Distress Syndrome (ARDS) Market - Company Scoring Matrix

Figure 97: Johnson & Johnson Services Inc. Financial Performance

Figure 98: Novartis AG Financial Performance

Figure 99: GlaxoSmithKline plc Financial Performance

Figure 100: Medtronic plc Financial Performance

Figure 101: Boehringer Ingelheim International GmbH Financial Performance

Figure 102: Global Acute Respiratory Distress Syndrome (ARDS) Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Acute Respiratory Distress Syndrome (ARDS) Market, Competitive Dashboard

Figure 104: Global Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Cause, 2025 – 2030

Figure 107: Global, Acute Respiratory Distress Syndrome (ARDS) Market Size Gain ($ Billion), Segmentation By Severity, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Respiratory Devices And Equipment (Diagnostic) Market Report 2026 - Global Outlook – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests,...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Acute Respiratory Distress Syndrome (ARDS) Market Report 2026 - Global Outlook – By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Oth...

Severe Acute Respiratory-Syndrome Treatment Market Report 2026 - Global Outlook – By Drug Class (Antibiotics, Antiviral, Corticosteroids, Monoclonal Antibodies, Other Drug Classes), By Route Of Administration (Oral, Intr...

Respiratory Disease Testing Market Report 2026 - Global Outlook – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Prod...

Acute Coronary Syndrome Market Report 2026 - Global Outlook – By Type (Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina), By Treatment (Statins, Beta blockers, ACE inhibitors, A...

Interstitial Lung Disease Market Report 2026 - Global Outlook – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonar...

Frequently Asked Questions

How big is the Acute Respiratory Distress Syndrome (ARDS) Market?

The Acute Respiratory Distress Syndrome (ARDS) market was valued at $1.41 billion in 2025, increased to $1.56 billion in 2026, and is projected to reach $2.42 billion by 2030. request a sample here

What is the Acute Respiratory Distress Syndrome (ARDS) market growth?

The global Acute Respiratory Distress Syndrome (ARDS) market is expected to grow at a CAGR of 11.7% from 2026 to 2035 to reach $2.42 billion by 2035. request a sample here

Who are the key players in Acute Respiratory Distress Syndrome (ARDS) market?

Some Key Players in the Acute Respiratory Distress Syndrome (ARDS) market Include, Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Medtronic plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, Smiths Medical Inc., Dräger Safety AG & Co. KGaA, Getinge AB, Mallinckrodt plc, Masimo Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Windtree Therapeutics Inc., Faron Pharmaceuticals Oy . request a sample here

What is the anticipated growth trend for the Acute Respiratory Distress Syndrome (ARDS) market?

Major trend in this market includes: Innovations In Immune Modulators Offer New Therapeutic Options In Acute Respiratory Distress Syndrome (ARDS). For further insights on this market. request a sample here

Which region has the most growth potential in the Acute Respiratory Distress Syndrome (ARDS) market?

North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2025. The regions covered in the acute respiratory distress syndrome (ards) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Acute Respiratory Distress Syndrome (ARDS) Market Report 2026 market?

Major companies operating in the Acute Respiratory Distress Syndrome (ARDS) Market Report 2026 market are Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Medtronic plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, Smiths Medical Inc., Dräger Safety AG & Co. KGaA, Getinge AB, Mallinckrodt plc, Masimo Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Windtree Therapeutics Inc., Faron Pharmaceuticals Oy request a sample here.

Which region has the most growth potential in the Acute Respiratory Distress Syndrome (ARDS) Market Report 2026 market?